Sheif Life: | 2 Years |
---|---|
Storage: | Cold Dry Place |
Deliver Time: | 7-10 Days |
Samples: | Available |
Purity: | >99% |
CAS: | 98319-26-7 |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Item Name | Specification |
Product Name | Finasteride |
CAS | 98319-26-7 |
Molecular Formula | C23H36N2O2 |
MW | 372.54 |
Grade Standard | Medicine Grade |
Appearance | white powder |
Purity | >99% |
Delivery time | Around 1-3 working days after your payment |
Guarantee | Full refund if you met any quality problem |
Finasteride was approved initially in 1992, a treatment for prostate enlargement, but the sponsor had studied 1 mg of finasteride and demonstrated hair growth in male pattern hair loss. On December 22, 1997, the FDA approved finasteride to treat male pattern hair loss.
1) Use for treatment of hair loss
2) For the treatment of benign prostatic hyperplasia, enlarged prostate shrink, improve urinary flow and improvement of benign prostatic hyperplasia caused symptoms.
Product Name | CAS No. | Product Name | CAS No. |
Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
Suppliers with verified business licenses